Skip to content

Advertisement

  • Poster presentation
  • Open Access

Effect of cyproheptadine on combat related PTSD nightmares

  • 1,
  • 1,
  • 1 and
  • 1
Annals of General Psychiatry20065 (Suppl 1) :S159

https://doi.org/10.1186/1744-859X-5-S1-S159

  • Published:

Keywords

  • Public Health
  • Patient Study
  • Stress Disorder
  • Trazodone
  • Open Trial

Background

Recent studies have shown the role serotonergic system in post-traumatic stress disorder. Trazodone and Nefazodone (5H2 antagonist) amilorated PTSD nightmares but the receptors are mixed. This study promoted an open trial of cyporoheptadine for Iran versus Iraq combat related PTSD patients nightmares.

Materials and methods

25 patients studies in 8 week, before after trial of cyproheptadine, the participant were male and chronic PTSD patients with combat related nightmares.

Results

5 patients were excluded from the study because of side effects including dizziness and somnolence. 20 patients completed the study. Average nightmare severity decreased from 6.85 to 5.05 which was statistically signifcant (p < 0.01).

Discussion

Cyproheptadine may be effective in PTSD nightmare treatment.

Authors’ Affiliations

(1)
Behavioral Science Research Center, Khorshid Medical Center Esfahan, Iran

References

  1. Harsh HH: Cyorheptatine for recurrent nighmares. Am J Psy. 1986, 143: 1491-1492.View ArticleGoogle Scholar

Copyright

© The Author(s) 2006

Advertisement